Trial Profile
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 1 diabetes with the Basal-Bolus Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2017 Status changed from recruiting to completed, based on the results published in the Diabetes Therapy.
- 01 Aug 2017 Results published in the Diabetes Therapy
- 25 Nov 2013 New trial record